advertising
Supported by
Half of Americans say they will get a coronavirus vaccine, according to a new survey, up from 72% in May. More than 40% of school workers are most at risk of serious cases of Covid-19.
Now
Utah officials announced 888 new cases, a one-day record for the state, that is still waiting to get reports from some regional fitness districts.
A strongly criticized tip from the Centers for Disease Control and Prevention last month about who should be tested for the coronavirus was not written through the CDC and published on the agency’s online page despite its serious objections, according to several other people close to the case as well as internal documents received through the New York Times.
The rules indicated that it was not mandatory to monitor others without Covid-19 symptoms even if they had been exposed to the virus. This came at a time when public fitness experts were asking for more controls than less, and management officials said The Times said the document was a CDC and had been reviewed with information from the agency’s director, Dr. Robert Redfield.
But he told The Times this week that the Department of Health and Human Services had rewritten it himself and then “dropped” it on the C. D. C. ‘s public website, ignoring the agency’s strict clinical review process.
“It was a document that came from the most sensible to the bottom, from HHS and the working group,” an informed federal official said, referring to the White House working group on coronavirus. “This policy doesn’t reflect what many other people are in the CDC’s feeling is political.
Admiral Brett Giroir, administration coordinator and deputy secretary of the Department of Health and Human Services, the CDC’s parent organization, said in an interview Thursday that the original assignment came here from the CDC, but that he “coordinated the edition and contribution. medical members of the group of brokers. “
Over a period of one month, he said, the draft had about 20 versions, with comments from Dr. Redfield; key members of the White House Working Group, Dr. Anthony Fauci and Dr. Deborah Birx; and Dr. Scott Atlas, President Trump’s coronavirus adviser. Members also presented the document to Vice President Mike Pence, who heads the working group, Admiral Giroir said.
CDC, scientists’ objections to the prepublished document have not been heard. A senior CDC official told scientists, “We don’t have the capacity to make really extensive changes,” according to an email received via The Times.
Similarly, a paper highlighting “the importance of reopening schools” was also presented on the C. D. C. Department of Health and Human Services’s online page. in July and is obviously not in tune with the same impartial and clinical tone as D. C. , the authorities said.
A new article published Thursday in the medical journal Health Affairs estimates that at least 42% of painters painting in US schools are estimated to have been able to do so. But it’s not the first time They are most at risk of serious cases of Covid-19, a significant increase in evidence of past threats to school painters. Training
Nearly 10 million adults paint in schools across the United States, adding teachers, principals, and staff, authors estimate. Previous studies have focused on teachers, concluding that about a quarter of them, or 1. 5 million, suffer from diseases that place them at the top. threat of serious coronavirus headaches.
The new study was expanded to read about all school employees, the knowledge of a family survey that collects detailed knowledge about the health, socioeconomics and employment of American families. The survey is conducted annually through the Federal Agency for Healthcare Research and Quality, a department of the Department of Health and Human Services.
The Federal Centers for Disease Control and Prevention lists several points that put others at the main threat of severe Covid-19 cases, adding obesity, diabetes, central illness, and being 65 or older. that at least 42% of school painters fall into at least one of these categories.
Obesity was the main factor in expanding the threat point of school employees, the authors reported, and staff were more likely than teachers or principals to be at maximum threat.
The authors did not draw general conclusions about the desirability of reopening classrooms, describing their findings on the number of school workers threatened as “a piece of the puzzle. “They noted that the application of methods through the CDC, the American Academy of Pediatrics, and the National Academies of Science, Engineering, and Medicine can help mitigate the threat of virus spread in schools.
As President Trump intensifies his promise of an effective coronavirus vaccine through Election Day, the percentage of Americans willing to take it has fallen rapidly, according to a new poll.
The Pew Research Group, which taught 10,093 U. S. adults from September 8-13, found that 51% of Americans said they would get the vaccine, representing a minimum of 21 percentage points since May, when 72 percent said they could simply do so.
Today, 49, in line with the percent of respondents, said they would “probably” or “certainly” do so.
78% of respondents felt that the progression procedure had been too hasty. While the self-proclaimed Republican electorate was less critical of the procedure than Democrats, a significant majority of both teams were skeptical of speed (despite repeated statements by the president that a vaccine that will be available in October, scientists, businesses, and federal officials say that, at most, others won’t get one until next year). In addition, 77% of respondents said they think a vaccine would be approved before its protection or efficacy. it is fully understood.
Messages about a possible vaccine have become very politicized. Trump has publicly rebuked Dr. Robert R. Redfield, director of the Centers for Disease Control and Prevention, after the doctor told a Senate subcommittee Wednesday that most Americans would not have access to a vaccine until next summer and that facial covers are more effective than a vaccine anyway.
The survey also found net divisions between races and ethnicities; 52% of white respondents said they would take a vaccine, compared to 32% of black respondents. Both figures are lower than in May. The maximum number of equipment likely to get a vaccine was Asians, with 72%, and Latinos with 56%.
California President Nancy Pelosi on Thursday doubled demands for a $2. 2 trillion stimulus bill, even as White House officials pointed to a smaller package that has generated little enthusiasm among Democratic leaders.
“It’s hard to see how we can approve of a decline when we see the wonderful needs,” Pelosi said at a press conference Thursday to call for more relief as the country approaches 200,000 pandemic deaths. He said Democrats had shown a willingness to commit to the White House by lowering their overall order from more than $1 trillion, to a $3. 4 trillion relief bill passed through the House in May.
At the White House, Mark Meadows, the White House staff leader, rejected Pelosi’s $2. 2 trillion request as “not a negotiation. “
“It’s an ultimatum,” he reports.
Backed by top-level Democrats, Pelosi continued to keep the company in number despite developing considerations from moderate Democrats that the stalemate over some other bailout will last until the November election, starving American families and businesses. of fundamental help. This past week, when Pelosi’s more level-headed lieutenants temporarily set out a $ 1. 5 trillion compromise framework presented through a bipartisan organization of lawmakers in an effort to break the deadlock.
However, President Trump said he was open to the proposal, presented through a coalition that called itself the House Problem Solver Caucus, a sentiment Trump echoed from Meadows.
“I’d like to see as many other people as possible,” Trump said at a white space news convention on Wednesday. “Yes, I’d like to see it. There are some things I don’t agree with yet. “I’m sure they can be negotiated. “
But Senate Republicans, who last week brought a rudimentary stimulus package that would provide $350 billion in new federal funds, are unlikely to adopt a much larger package.
transcript
So here’s the updated technique we’re going to take, and it’s multi-phase. They move quickly, so we can serve young people and families well. But they will come with some changes from the previous schedule. So this is who we are. I’m going to do. Starting this Monday, September 21, the preschools of 3-K and pre-K will be open, the pre-K and 3-K categories will be open, the schools of the 7th District, the schools that serve our young people in special education, the young people who love and love, those schools will be open. Then we will have the next phase on Tuesday, September 29, when K to 5 schools and K schools will open to 8, and then on Thursday, October 1, Schools and the best schools will open. Now this means in-person learning, distance learning has obviously already begun. Guidance has begun, distance learning will continue for all academics as those stages come into play.
New York City Mayor Bill de Blasio delayed the start of the top head-to-head categories in public schools on Thursday, acknowledging that the formula had not yet fully triumphed over the many obstacles it faced in returning to the young people the coronavirus pandemic.
The abrupt announcement struck the mayor’s efforts to make New York one of the few major cities in the country to teach face-to-face classes and threatened to deepen considerations and confusion over whether the mayor and his management had mis handlered the reopening by pronouncing and then pushing them back.
Instead of a triumphant return to schools for all students who sought face-to-face learning starting Monday, the city will bring students back to the study rooms on an ongoing basis, starting with younger children, who will show up for Next Week Pre-K students and students with complex special desires will return on Monday.
On September 29, number one schools will open and schools and the best schools will open on October 1.
All other students will start the school year remotely on Monday.
The mayor said at a press conference Thursday morning that he had to opt for a slow reopening after having a multi-hour verbal exchange Wednesday with union leaders representing the city’s directors and teachers.
These union leaders have explicitly warned for weeks that schools were not in a position to reopen for a thousand reasons, ranging from poor ventilation in some old buildings to severe staff shortages that, according to the principals’ union, could leave the city in search of 10,000 educators.
Mr. de Blasio said the shortage of the instructor is his main explanation for delaying face-to-face categories again.
“We are doing this to make sure that all the criteria we have set are met,” Mr. de Blasio said Thursday morning, adding that the reopening plan evolved through the reading of “best practices from around the world. “
More than 40% of parents have already chosen to attend the categories in person, and that number is likely to increase, reflecting the deep frustration of families with efforts to reopen the city and skepticism about school readiness.
transcript
We have a very serious scenario ahead of us: the weekly instances have surpassed those reported when the pandemic first arrived in Europe in March; last week, the region’s weekly count exceeded 300,000 patients; more than part of European countries have reported an increase. more than 10% in cases in the last two weeks. Of these, seven countries recorded new cases more than double during the same period. In the spring and early summer, we saw the effect of strict blocking measures. efforts, our sacrifices have paid off. In June, cases reached an all-time low. However, September case numbers deserve to serve as a reminder to all of us. While these figures reflect more comprehensive evidence, they also show alarming transmission rates across the region.
The World Health Organization warned Thursday of a “very serious” resurgence of coronavirus in Europe, but said transmission could be limited through local than national measures.
Hans Kluge, regional director of the O. H. O. , told reporters”We have a very serious scenario unfolding before us. For Europe. Weekly cases have now surpassed those reported when the pandemic peaked in Europe in March. “
The number of cases of viruses has increased by more than 10% in the last two weeks in more than Part of European countries, said Dr. Kluge, who noted that in seven countries the number of cases had doubled.
“While those figures are more comprehensive evidence, they also show alarming transmission rates,” he said. The region has recorded at least 220,000 deaths from the virus.
“In many cases, those spikes can be involved locally,” he added. “In this regard, I hope that national closures have been avoided as much as possible. “
British fitness secretary said Thursday that nearly two million people in north-east England would be barred from bringing other people outdoors into their homes as a component of the country’s newest local closures.
And in France, a number of developing cities, including Lyon and Nice, are experiencing a worrying spread of coronavirus and will have to enact new restrictions on public meetings, the French fitness minister said Thursday.
The rate of new instances consistent with the inhabitant in France over the more than seven days is lately one of the highest in Europe, with 91 instances consisting of 100,000 inhabitants, compared to 10 at the end of July. Meetings of families and friends have “massive” vectors of infections, said Olivier Véran, the country’s fitness minister.
In the Czech Republic, about a quarter of the country’s 41,000 total cases have been reported in the following week, as the country is facing one of the fastest-developing outbreaks in Europe. For a full blockade, the government has reintroduced specific restrictive measures, adding a ban on indoor meetings for more than 10 people, mandatory indoor masking and reduced hours for bars and restaurants.
Biotechnology company Moderna published a 135-page paper thursday detailing how it is achieving the complex trial of its coronavirus vaccine and how protection and efficacy will be determined.
The paper suggests that the first research into the knowledge of the trial might not be conducted until the end of December and that there may not be enough data to know if the vaccine is working. Subsequent analyses, scheduled for March and May, are most likely to give an answer.
The company is one of the pioneers in the race to produce a vaccine to fight the pandemic. The Modernna vaccine uses the genetic material of the virus, called mRN, to induce the body’s cells to produce a fragment of the virus that will cause the immune formula to fight an infection.
The vaccine is now in a Phase 3 exam that has recruited more than 25,000 of the 30,000 planned volunteers, and Dr. Tal Zaks, Moderna’s leading medical officer, said recruitment will end in the coming weeks.
Approximately 28% of the participants are black, Latino or other teams affected by the disease. A varied directory that is considered essential.
Half of the participants get the vaccine and the part gets a placebo vaccine consisting of salt water. Two strokes are required, 4 weeks apart. Participants are then monitored to see if they expand Covid-19 symptoms and are positive for the virus.
The side effects of the vaccine are also monitored, participants record symptoms in electronic journals, take their own temperature, go to the clinic and receive regular phone calls to assess their condition. The vaccine can cause brief reactions such as arm pain, fever, chills, muscle and joint pain, fatigue and headache.
For the effectiveness of the vaccine, Covid-19 instances are counted only if they occur two weeks after the time of injection. Some patients are already two weeks after the time of the injection, but Dr. Zaks said he did not know if there were participants in the trial. had still contracted Covid-19.
A total of 151 cases, divided between vaccine and placebo teams, will be sufficient to determine whether the vaccine is 60% effective. The Food and Drug Administration has set the bar at 50, according to the penny.
ad